Stage I–II colon cancers are generally managed with surgery alone, often achieving cure rates above 90%, whereas stage III disease commonly requires postoperative chemotherapy for optimal outcomes.

Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped ...

One woman is sharing a look inside her life after completing her cancer treatment. Meagan Meadows was just 24 years old when she found blood in her stool, leading her to medical tests that would ...

ROCHESTER, Minn. — Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer ...

Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent) to a ...

The ATOMIC Trial shows how adding immunotherapy to chemotherapy may reduce recurrence risk and improve outcomes in stage III dMMR colon cancer. To better understand the role of immunotherapy in colon ...

Add Yahoo as a preferred source to see more of our stories on Google. Shambi Broome had virtually no symptoms of colon cancer. She got a colonoscopy when she reached the annual screening age, lowered ...

The Food and Drug Administration (FDA) has granted Priority Review to the supplemental Biologics License Applications (sBLAs) for adjuvant atezolizumab (Tecentriq ®) and atezolizumab and hyaluronidase ...

The Alliance for Clinical Trials in Oncology (Alliance) today announced that the U.S. Food and Drug Administration has accepted for review Genentech's supplemental Biologic License Application for ...

Meagan Meadows was diagnosed with stage 3 colon cancer at just 24, but she rang the bell after her last round of chemo exactly eight months later Meagan Meadows was diagnosed with stage 3 colon cancer ...

Meagan Meadows was diagnosed with stage 3 colon cancer at just 24, but she rang the bell after her last round of chemo exactly eight months later Sara Belcher is a digital news writer/editor at PEOPLE ...